Salicylic acid

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet, which is debossed with "A" on one side and "123" on the other. Each tablet contains 500 mg of Acetaminophen. The formulation includes the following inactive ingredients: microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol, talc, iron oxide red, and iron oxide yellow.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, 'cauliflower-like' surface appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to administer one patch per day. Each patch contains 1 mg of Salicylic acid. The patch should be applied to the affected area, ensuring that the skin is clean and dry prior to application. It is important to follow the recommended dosing schedule to achieve optimal therapeutic effects.

Contraindications

Use is contraindicated in the following situations:

Application is not recommended on irritated, infected, or reddened skin due to the potential for exacerbation of these conditions. The product should not be applied to genital warts or warts located on the face, as these areas may be sensitive and could lead to adverse reactions. Additionally, the use of this product is contraindicated on moles, birthmarks, and warts with hair growing from them, as these may indicate underlying conditions that require different management. Finally, application to mucous membranes is contraindicated to avoid irritation and potential harm.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have diabetes or experience poor blood circulation, as these conditions may increase the risk of adverse effects.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients must be instructed to discontinue use and contact their healthcare provider if any of the following conditions are present: the product is applied to irritated, infected, or reddened skin; it is used on genital warts or warts located on the face; it is applied to moles, birthmarks, or warts with hair growing from them; or if it comes into contact with mucous membranes. These precautions are essential to ensure patient safety and prevent potential complications.

Side Effects

Patients should be aware that the product is intended for external use only. Adverse reactions associated with the use of this product may vary in severity and frequency.

In clinical trials, participants reported a range of adverse reactions, although specific data on the frequency and seriousness of these reactions were not provided. Postmarketing experiences may also reveal additional adverse reactions that were not observed during clinical trials.

It is essential for patients to monitor for any unexpected effects and to consult healthcare professionals if they experience any adverse reactions while using the product.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Skin Care Removal. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in the absence of established safety profiles. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There is no specific information regarding the use of the Skin Care Removal Patch in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, there is currently no specific information available regarding the effects or management of such an occurrence. Healthcare professionals are advised to monitor the patient closely and provide supportive care as needed. It is essential to assess the patient's clinical status and implement standard emergency protocols for overdose situations.

In the absence of detailed guidance, practitioners should consider consulting local poison control centers or relevant medical literature for additional support and recommendations on managing potential overdosage scenarios.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the medication is not to be used on irritated, infected, or reddened skin. It is also important to emphasize that the medication should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be cautioned against using the medication on mucous membranes.

Healthcare providers should encourage patients to consult with a doctor prior to use if they have diabetes or poor blood circulation, ensuring that any potential risks are adequately addressed.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be observed to prevent any compromise to the product's quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Skin Care Removal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)